Guide to Clinical Management of Idiopathic Pulmonary Fibrosis
Nonfiction, Health & Well Being, Medical, Specialties, Pulmonary & Thoracic
| Author: | Steven D Nathan, A Whitney Brown, Christopher S King | ISBN: | 9783319327945 |
| Publisher: | Springer International Publishing | Publication: | July 27, 2016 |
| Imprint: | Adis | Language: | English |
| Author: | Steven D Nathan, A Whitney Brown, Christopher S King |
| ISBN: | 9783319327945 |
| Publisher: | Springer International Publishing |
| Publication: | July 27, 2016 |
| Imprint: | Adis |
| Language: | English |
This clinically focused pocket guide offers a concise yet complete overview of idiopathic pulmonary fibrosis, covering the most recent information on aspects such as pathophysiology, management, treatment, and clinical trials. The text is easily accessible and offers pulmonologists and other health care professionals with an excellent quick reference tool. Full color images and figures enhance and summarize key aspects of the text.
Idiopathic pulmonary fibrosis is a condition that affects the alveoli and leads to serious lung damage, and the idiopathic nature of this disease means that the origin or cause is unknown. This disease is relatively rare, affecting 3 in 10,000 people, but it is becoming more common. Physicians should be aware of the early stages and symptoms of this disease so management strategies can be implemented quickly, and the best treatment can be administered.
This clinically focused pocket guide offers a concise yet complete overview of idiopathic pulmonary fibrosis, covering the most recent information on aspects such as pathophysiology, management, treatment, and clinical trials. The text is easily accessible and offers pulmonologists and other health care professionals with an excellent quick reference tool. Full color images and figures enhance and summarize key aspects of the text.
Idiopathic pulmonary fibrosis is a condition that affects the alveoli and leads to serious lung damage, and the idiopathic nature of this disease means that the origin or cause is unknown. This disease is relatively rare, affecting 3 in 10,000 people, but it is becoming more common. Physicians should be aware of the early stages and symptoms of this disease so management strategies can be implemented quickly, and the best treatment can be administered.
